SCHEMBL18136387

SCHEMBL18136387

CC(=O)OC[C@H]1O[C@@H](Oc2cc3cc(Br)c(Br)cc3cc2O)[C@@H](OC(C)=O)C1OC(C)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HB P07237 1/20 0.48
PDIA4 P13667 1/20 0.48
PDIA3 P30101 1/20 0.48
CYP2D6 P10635 1/20 0.47
THRB P10828 1/20 0.47
HSD17B10 Q99714 1/20 0.47
CA12 O43570 2/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
CA4 P22748 2/20 0.46
CA5A P35218 2/20 0.46
CA7 P43166 2/20 0.46
CA5B Q9Y2D0 2/20 0.46
PTPN1 P18031 2/20 0.44
PTPN2 P17706 1/20 0.44
PTPN11 Q06124 1/20 0.44
TSHR P16473 1/20 0.44
MEN1 O00255 2/20 0.44
CYP3A4 P08684 2/20 0.44
KMT2A Q03164 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16710245 1.00 P4HB (0.48) P4HBPDIA4PDIA3CYP2D6THRB
SCHEMBL20035054 1.00 P4HB (0.48) P4HBPDIA4PDIA3CYP2D6THRB
SCHEMBL16710230 0.99 P4HB (0.49) P4HBPDIA4PDIA3CYP2D6THRB
SCHEMBL18134223 0.93 P4HB (0.42) P4HBPDIA4PDIA3CYP2D6THRB
SCHEMBL18134224 0.92 P4HB (0.42) P4HBPDIA4PDIA3CYP2D6THRB
SCHEMBL20035072 0.88 P4HB (0.53) P4HBPDIA4PDIA3CYP2D6THRB
SCHEMBL16710235 0.88 P4HB (0.53) P4HBPDIA4PDIA3CYP2D6THRB
SCHEMBL18136409 0.88 P4HB (0.53) P4HBPDIA4PDIA3CYP2D6THRB
SCHEMBL20035071 0.88 P4HB (0.53) P4HBPDIA4PDIA3CYP2D6THRB
SCHEMBL20633948 0.87 TSHR (0.55) P4HBPDIA4PDIA3CYP2D6THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160298167-A1 NAPHTHALENE DERIVED CHROMOGENIC ENZYME SUBSTRATES GLYCOSYNTH LIMITED (GB) 2016-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160298167-A1 NAPHTHALENE DERIVED CHROMOGENIC ENZYME SUBSTRATES CYP2R1, TDO2, XDH P4HB 537/4885PDIA4 2590/4885PDIA3 2570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.